US FDA Approves New Indication For CRESTOR® (Rosuvastatin Calcium)

Links shared publicly online about this topic.

  • 1,392
    total visits

US FDA Approves New Indication For CRESTOR® (Rosuvastatin Calcium)

medicalnewstoday.com

AstraZeneca (NYSE: AZN) announced that the US Food and Drug Administration (FDA) has approved CRESTOR® (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction (heart attack)

View full resource at medicalnewstoday.com

Tags: Cholesterol Medication, Mineral, Calcium, Drug, Supplement, FDA, Crestor, AstraZeneca

  • Share

Most Recently Shared on February 10, 2010 at 7:13 pm By:

mnt_clinical MNT Clinical Trials

US FDA Approves New Indication For CRESTOR® (Rosuvastatin Calcium) http://mnt.to/3xrb #clinicaltrials

2 years ago...

Also Shared By:

medical_tweets medical_tweets

MNT Cardiovascular MNT Cardiovascular

Bayer HealthCare receives FDA approval for Natazia to treat HMB

news-medical.net — “Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 4:43 am By:

NewsMedical News-Medical.Net Health News

Bayer HealthCare receives FDA approval for Natazia to treat HMB: Bayer HealthCare Pharmaceuticals Inc. today ann... http://t.co/owLKhz1u

2 months ago...

Baxter U.S. - Baxter Announces FDA Approval of ARTISS Fibrin Sealant For Use in Face-Lift (Facial Rhytidectomy) Procedures

baxter.com — “Baxter Announces FDA Approval of ARTISS Fibrin Sealant For Use in Face-Lift (Facial Rhytidectomy) ProceduresView full resource at baxter.com

  • View Related
  • Share

Most Recently Shared on September 6, 2011 at 2:30 pm By:

baxter_intl Baxter International Pharma

Baxter announces FDA approval of new indication for ARTISS http://t.co/l3P63Q0

8 months ago...

U.S. Food and Drug Administration Approves Gilead Sciences' Complera, a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naïve Adults

drugs.com — “Complera (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) is used to treat HIV infection. Includes Complera side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 10, 2011 at 11:27 pm By:

drugscom Drugs.com Health Site

FDA Approves Complera, a Once-Daily, Single-Tablet Regimen for HIV-1 Infection - http://bit.ly/nXmNLg

9 months ago...

Watson seeks FDA approval to market generic version of Pfizer's Viagra

news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Sildenafil Citrate Tablets, 25, 50 and 100 mg. Watson's Sildenafil Citrate tablets are a generic version of Pfizer Inc.'s Viagra®, which is indicated for the treatment of erectile dysfunction (ED).View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on June 3, 2011 at 12:47 pm By:

NewsMedical News-Medical.Net Health News

Watson seeks FDA approval to market generic version of Pfizer's Viagra: Watson Pharmaceuticals, Inc. today confi... http://bit.ly/jEYgoE

11 months ago...

FDA Approves New HIV Treatment Edurant (rilpivirine)

drugs.com — “Edurant (rilpivirine) is used to treat HIV-1 infection. Includes Edurant side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on May 21, 2011 at 1:04 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Approves New HIV Treatment Edurant (rilpivirine): May 20, 2011 -- The U.S. Food and Drug Administratio... http://bit.ly/lP7KHQ #drug

11 months ago...

FDA approves expanded access to RX Acculink stent for clogged neck artery treatment

news-medical.net — “The U.S. Food and Drug Administration today approved an expanded indication that will allow a new group of patients at risk of stroke due to clogged neck arteries to be treated with the RX Acculink carotid stent.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on May 7, 2011 at 9:39 am By:

NewsMedical News-Medical.Net Health News

FDA approves expanded access to RX Acculink stent for clogged neck artery treatment: The U.S. Food and Drug Admi... http://bit.ly/lulxVT

12 months ago...

FDA Expands Approved Use For Carotid Stent

medicalnewstoday.com — “The U.S. Food and Drug Administration today approved an expanded indication that will allow a new group of patients at risk of stroke due to clogged neck arteries to be treated with the RX AcculinView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on May 6, 2011 at 5:05 pm By:

UCSF scientists play key role in success of Yervoy, a new cancer drug

medicalxpress.com — “Yervoy is unlikely to win a contest for best named drug, but recent US Food and Drug Administration (FDA) approval for the new entrant in the battle against cancer marks the success of a novel treatment strategy, and is another indicator that immunotherapy has gone mainstream.View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on May 6, 2011 at 1:52 pm By:

physorg_health PhysOrg Health News Health News

UCSF scientists play key role in success of Yervoy, a new cancer drug http://tw.medicalxpress.com/223894307

12 months ago...

FDA considers new rules to speed up confirmatory trials of drugs granted accelerated approval

physorg.com — “Since 1992, the U.S. Food and Drug Administration has granted accelerated approval to 47 new indications for 35 cancer drugs and in more than half the cases—26 indications—further trials have confirmed the benefits of the drugs. But the agency has concerns about the length of time some drugs ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on March 25, 2011 at 9:23 pm By:

physorg_health PhysOrg Health News Health News

FDA considers new rules to speed up confirmatory trials of drugs granted accelerated approval http://tw.physorg.com/220292446

1 year ago...

FDA Considers New Rules To Speed Up Confirmatory Trials Of Cancer Drugs Granted Accelerated Approval

medicalnewstoday.com — “Since 1992, the U.S. Food and Drug Administration has granted accelerated approval to 47 new indications for 35 cancer drugs and in more than half the cases - 26 indications - further trials haveView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on March 25, 2011 at 8:05 pm By:

mnt_cancer MNT Cancer News Health News

FDA Considers New Rules To Speed Up Confirmatory Trials Of Cancer Drugs Granted Accelerated Approval http://mnt.to/3SHM #cancer

1 year ago...

New HPV Vaccine Indication, February 23, 2011, Kuehn 305 (8): 770 --" JAMA

jama.ama-assn.org — “New HPV Vaccine Indication, February 23, 2011, Kuehn 305 (8): 770 --" JAMAView full resource at jama.ama-assn.org

  • View Related
  • Share

Most Recently Shared on February 23, 2011 at 2:19 am By:

HPV_Wisdom OrganizedWisdom HPV OW Health

New HPV Vaccine Indication [Health Agencies Update]: The US Food and Drug Administration (FDA) has approved the ... http://bit.ly/eWhyXf

1 year ago...

Hi-Tech Pharmacal Receives Final Approval For Levofloxacin Ophthalmic Solution - QualityPoint Technologies

qualitypointtech.net — “Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK), a specialty pharmaceuticals company, announced that the US Food and Drug Administration, (FDA) granted final approval for the Company's Abbreviated New Drug Application, (ANDA) for levofloxacin ophthalmic solution, 0.5% the generic for Vistakon's Quixin® ophthalmic solution, which had sales of $2 million for the 12 months ended December 2010 according to IMS sales data. The product is indicated for bacterial conjunctivitis. The Company is preparing View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on February 13, 2011 at 11:35 am By:

MedicalFeed MedicalFeed Health News Feed

Hi-Tech Pharmacal Receives Final Approval For Levofloxacin Ophthalmic Solution: Hi-Tech Pharmacal Co., Inc. (NASDA... http://bit.ly/edWqEF

1 year ago...

FDA Approves New Dosage Strength For INTELENCE(R)

medicalnewstoday.com — “The U.S. Food and Drug Administration(FDA) approved a label update to include a 200 mg formulation of INTELENCE® (etravirine), a non-nucleoside reverse transcriptase inhibitor (NNRTI) indicateView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 4, 2011 at 5:05 pm By:

FDA Approves New Dosage Strength for Intelence

drugs.com — “Intelence (etravirine) is used to treat HIV infection. Includes Intelence side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on January 4, 2011 at 4:10 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA Approves New Dosage Strength for Intelence: TITUSVILLE, N.J., Jan. 3, 2011 /PRNewswire/ -- The U.S. Fo... http://bit.ly/fCWTaJ #drug

1 year ago...

US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL® | Business Wire

businesswire.com — “Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL®View full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on December 22, 2010 at 10:33 pm By:

HPV_Wisdom OrganizedWisdom HPV OW Health

US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL®: WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Me... http://bit.ly/eqNp7F

1 year ago...

Advertisement